Connect with us
Information
About Us
Contact Us
Careers
Partnerships
Advertise With Us
Authors
Browse Topics
Events
Disclaimer
Privacy Policy
Australia
North America
World
Login
Investing News
Network
Your trusted source for investing success
North America
Australia
World
My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
Reports & Guides
Market Outlook Reports
Investing Guides
Resource
Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals
Tech
Life Science
nasdaq:adap
POPULAR ARTICLES
Adaptimmune Therapeutics Receives Advanced Therapy Designation
Adaptimmune Therapeutics Receives Orphan Drug Designation
Adaptimmune and Noile-Immune to Develop SPEAR T-Cell Products
LATEST ARTICLES
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products
5 Top Weekly NASDAQ Biotech Stocks: Dova Up 41 Percent
Biotech Trends 2018: Immuno-oncology Disappoints
8 Top Gains and Losses at 2018’s ESMO Event
Pharmaceutical Investing
Pharmaceutical Update: Q3 2018 in Review
Latest News
Westport Announces Annual General and Special Meeting and Timing of Q1 2025 Financial Results
Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties
Canadian Investment Regulatory Organization Trade Resumption - FYL
Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties
Forte Minerals Engages Trion Communications GmbH for European Investor Awareness
More News
